Literature DB >> 6395885

Molecular characteristics of the major scrapie prion protein.

D C Bolton, M P McKinley, S B Prusiner.   

Abstract

A major protein was identified that purifies with the scrapie agent extracted from infected hamster brains. The protein, designated PrP 27-30, was differentiated from other proteins in purified fractions containing the scrapie agent by its microheterogeneity (Mr 27000-30000) and its unusual resistance to protease digestion. PrP 27-30 was found in all fractions enriched for scrapie prions by discontinuous sucrose gradient sedimentation or sodium dodecyl sarcosinate-agarose gel electrophoresis. It is unlikely that PrP 27-30 is a pathologic product because it was found in fractions isolated from the brains of hamsters sacrificed prior to the appearance of histopathology. If PrP 27-30 is present in normal brain, its concentration must be 100-fold lower than that found in equivalent fractions from scrapie-infected hamsters. Three protease-resistant proteins similar to PrP 27-30 were found in fractions obtained by discontinuous sucrose gradient sedimentation of scrapie-infected mouse brain. These proteins were not evident in corresponding fractions prepared from normal mouse brain. One-dimensional peptide maps comparing PrP 27-30 and normal hamster brain proteins of similar molecular weight demonstrated that PrP 27-30 has a primary structure which is distinct from these normal proteins. Heating substantially purified scrapie fractions to 100 degrees C in sodium dodecyl sulfate inactivated the prion and rendered PrP 27-30 susceptible to protease digestion. Though the scrapie agent appears to be hydrophobic, PrP 27-30 remained in the aqueous phase after extraction with organic solvents, indicating that it is probably not a proteolipid. PrP 27-30 is the first structural component of the scrapie prion to be identified.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6395885     DOI: 10.1021/bi00320a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  Recombinant prion protein does not possess SOD-1 activity.

Authors:  Samantha Jones; Mark Batchelor; Daljit Bhelt; Anthony R Clarke; John Collinge; Graham S Jackson
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

2.  A 54-kDa normal cellular protein may be the precursor of the scrapie agent protease-resistant protein.

Authors:  P E Bendheim; D C Bolton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains.

Authors:  R J Kascsak; R Rubenstein; P A Merz; R I Carp; N K Robakis; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

Review 4.  Prion liposomes.

Authors:  R Gabizon; S B Prusiner
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

5.  Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.

Authors:  J M Bockman; D T Kingsbury
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  Scrapie and Creutzfeldt-Jakob disease prion proteins share physical properties and antigenic determinants.

Authors:  P E Bendheim; J M Bockman; M P McKinley; D T Kingsbury; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 7.  The map of chromosome 20.

Authors:  N E Simpson
Journal:  J Med Genet       Date:  1988-12       Impact factor: 6.318

8.  Scrapie prion proteins are synthesized in neurons.

Authors:  H A Kretzschmar; S B Prusiner; L E Stowring; S J DeArmond
Journal:  Am J Pathol       Date:  1986-01       Impact factor: 4.307

Review 9.  On the biology of prions.

Authors:  S B Prusiner; R Gabizon; M P McKinley
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 10.  Scrapie strain infection in vitro induces changes in neuronal cells.

Authors:  R Rubenstein; H Deng; R Race; W Ju; C Scalici; M Papini; A Rubenstein; R Kascsak; R Carp
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.